Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

VENUS REMEDIES LTD.

NSE : VENUSREMBSE : 526953ISIN CODE : INE411B01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE784.6524.6 (+3.24 %)
PREV CLOSE () 760.05
OPEN PRICE () 736.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1933
TODAY'S LOW / HIGH ()736.00 788.00
52 WK LOW / HIGH ()275 848.9
NSE781.5036.05 (+4.84 %)
PREV CLOSE() 745.45
OPEN PRICE () 759.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 35570
TODAY'S LOW / HIGH() 745.45 782.70
52 WK LOW / HIGH ()271.85 839.9
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1989

Management Info :

Pawan Chaudhary - Chairman Pawan Chaudhary - Managing Director

Registered Office :

Address : S. C. O. 857, C. No. 10,2nd Floor,N A C Manimajra,
Chandigarh,
Union Territory-160101

Phone : 0172-2561244/5577

Registrar's Details : MUFG Intime India Pvt Ltd.
Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi
Listing : BSE, NSE
NEWS
19Jan Venus Remedies informs about board mee
Venus Remedies has informed that the meeting of Board of Directors is sc..
09Jan Venus Remedies gets marketing authoriz
Venus Remedies has received marketing authorisation in Indonesia for its..
09Jan Venus Remedies soars on getting market
Venus Remedies is currently trading at Rs. 727.00, up by 15.75 points or..
08Dec Venus Remedies informs about press rel
Venus Remedies has informed about press release titled - 'Venus Remedies..
01Dec Venus Remedies informs about update o
Venus Remedies has informed that the company has concluded all pending I..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit249.2525.5
Gross Profit 328.1 790.6
Operating Profit 391.3907.7
Net Sales 1799.56394.6
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Gland Pharma (BSE)
 1799.40 (6.56%)
M.Cap ( in Cr)
29646.27
NGL Fine-Chem (BSE)
 1785.00 (4.58%)
M.Cap ( in Cr)
1102.78
Acutaas Chemicals (BSE)
 1936.00 (3.84%)
M.Cap ( in Cr)
15850.25
Windlas Biotech (BSE)
 823.95 (4.76%)
M.Cap ( in Cr)
1736.66
Ipca Laboratories (BSE)
 1482.10 (2.36%)
M.Cap ( in Cr)
37601.50
Shareholding Pattern
NON-INSTITUTION 54.96%
PROMOTERS 41.76%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
No Data Found
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX82566.37221.69 (0.27%)
NIFTY25418.9076.15 (0.30%)
Dow Jones 49015.6012.19 (0.02%)
Nasdaq 23857.4540.35 (0.17%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI